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Although still in an early stage, this 
approach represents a novel and simple 
way to optimize the benefits of topical 
NO as a local biologic mediator.
Although NO-releasing zeolites may 
not be the last answer, it is to the credit of 
Mowbray et al. that they have designed 
a system of applying pure NO in a con-
trolled and predictable manner without 
causing an inflammatory reaction in 
human skin. Wound healing is a partic-
ularly interesting application, given the 
multiple benefits that NO might have, 
depending on its concentration and the 
kinetics of delivery. Central to the suc-
cess of NO donor therapy is generation 
of the correct amount of NO in the right 
place for the right length of time. Solving 
these problems will undoubtedly lead to 
new NO donor therapies for skin diseas-
es and disorders.
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Neuroimmune Communication in 
Skin: Far from Peripheral
Sven Hendrix1
The precise nature of the link between stress and exacerbation of skin inflam-
mation has puzzled researchers and clinicians alike. The traditional expla-
nation is that immune balance is altered by activation of two stress axes: 
activation of the hypothalamic–pituitary–adrenal (HPA) axis raises cortisol lev-
els, and activation of the sympathetic nervous systems raises adrenaline levels 
(Figure 1). In this issue, Pavlovic et al. (2008) provide evidence for a third stress 
axis and report that stress travels to the skin through peripheral neuropeptider-
gic nerve fibers and exacerbates the neurogenic inflammatory aspect of cuta-
neous dermatitis. Clarification of the role of this alternative stress axis may 
enable the design of novel therapeutic strategies.
Journal of Investigative Dermatology (2008), 128, 260–261. doi:10.1038/sj.jid.5701171
Pathologies that involve chronic 
relapse and significant discomfort, 
such as atopic dermatitis, are regarded 
as psychosomatic dermatoses (Wright 
et al., 2005). In the early days of psy-
choanalysis, the skin was regarded as 
one vehicle by which the body and 
soul express the feelings and well-
being of its bearer. Itchy and inflamed 
skin was interpreted as a cry for atten-
tion and help and a sign of severe 
deprivation of tenderness and care.
In the past, the close interaction 
between neuropeptidergic nerve fibers 
and immune cells in the skin was 
widely understood as playing a role in 
the cutaneous stress response. Altered 
nerve-fiber counts in atopic dermatitis, 
psoriasis, nummular eczema, and many 
other—mostly chronic and inflamma-
tory—skin pathologies were viewed as 
evidence of the possible influence of 
stress on the course of inflammation.
In parallel, stress research pro-
vided evidence of a close interaction 
between nerve fibers and, for exam-
ple, mast cells under stress (rang-
ing from physical to psychological) 
(Theoharides and Cochrane, 2004). 
The idea that mast cells are activated 
under conditions of stress in exac-
erbated inflammatory skin disease 
became accepted almost to the point 
of textbook knowledge, even though 
experimental evidence has still not 
been provided.
Initial insights into the pathogen-
esis of stress-induced exacerbation of 
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cutaneous inflammation were provided 
by studies showing a decreased acute 
excitability of the HPA axis and chroni-
cally elevated basal levels of cortisol 
(Buske-Kirschbaum et al., 2001). Such 
an imbalance in the stress response is 
commonly associated with an imbal-
ance in the immune response, with a 
predominance of so-called T helper 
cell type 2 cytokines, such as interleu-
kin-4 and -5. Because this constella-
tion was observed in both chronically 
stressed and atopic dermatitis patients, 
it was hypothesized that chronic stress 
exposure facilitates allergy develop-
ment. On the other hand, frequently 
observed exacerbation after exposure 
to acute stress remained unexplained.
The study by Pavlovic and col-
leagues provides the first complex 
experimental evidence that stress influ-
ences skin homeostasis via peripheral 
neuropeptidergic nerve fibers, which 
in turn activate mast cells by secret-
ing neuropeptides such as substance 
P (“neurogenic inflammation”). Mast 
cell degranulation provides multiple 
mediators that activate endothelial 
cells, leading to effects such as the 
development of erythema and edema. 
Thus, neurogenic inflammation exac-
erbates cutaneous dermatitis.
The authors have demonstrated a 
plausible chain of events that goes a 
long way toward explaining to phy-
sicians and their patients the role of 
stressful life events in the exacerba-
tion of inflammatory skin disease. 
Furthermore, this concept helps to 
focus research on a third stress axis, 
which may be therapeutically manip-
ulated. However, the role of T helper 
cells in this new hypothesis could be 
understated because these may play 
a key role in modulating cutaneous 
neuronal plasticity (and, as a conse-
quence, neurogenic inflammation as 
well) via secreted factors such as cyto-
kines and neurotrophins (Hendrix and 
Nitsch, 2007). It will be particularly 
interesting to see whether the cardi-
nal symptom of neurogenic inflam-
mation—itch—can also be therapeuti-
cally influenced by antagonists to the 
substance P receptor neurokinin-1.
The organs protecting the borders 
of our body, such as skin, lung, or gut, 
which are frequently challenged by a 
wide variety of stressors, are character-
ized by dense innervation. Therefore, 
similar interactions between periph-
eral nerve fibers and targeted mast 
cells, as shown in skin by Pavlovic 
and colleagues, may also account for 
stress effects in other potentially stress-
sensitive organs. Thus, a third stress 
axis has been added to the two classi-
cal models that has equal potential in 
terms of explaining pathogenesis and 
promoting the therapy of stress-sensi-
tive cutaneous inflammation (Figure 
1). However, its rank in the cascade of 
events following stress exposure is still 
unclear, and comparative analysis of 
the central, as well as the peripheral, 
stress response is urgently required.
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Figure 1. Three stress axes exacerbating inflammatory skin disease. HPA, hypothalamic–pituitary–
adrenal axis; TH2, T helper cell type 2 cytokine milieu.
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Stress inﬂuences 
skin homeostasis 
via peripheral 
neuropeptidergic nerve 
ﬁbers.
